Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -0.26% is 108% below its 5-year average of 3.44%, around the middle of its 5-year range (-14.87%–6.18%).
As of the fiscal period ended Tuesday, June 30, 2026. 106.62% below its 12-month average of 3.92%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -0.26%.
RETURN ON INVESTED CAPITAL (ROIC)
-0.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
3.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-1.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
3.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-106.62%
CURRENT VS 3Y AVG
+84.60%
CURRENT VS 5Y AVG
-107.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 669 covered companies
CURRENT VS SECTOR MEDIAN
+99.23%
vs the sector median at left
AdaptHealth Corp.
Market Cap
$795.58M
Return on Invested Capital (ROIC)
-0.26%
TTM Avg
3.92%
3Y Avg
-1.69%
5Y Avg
3.44%
Market Cap
$796.03M
Return on Invested Capital (ROIC)
-9.77%
TTM Avg
8.57%
3Y Avg
-11.39%
5Y Avg
-51.99%
Market Cap
$790.35M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
-22.82%
3Y Avg
-51.67%
5Y Avg
-50.32%
Market Cap
$787.65M
Return on Invested Capital (ROIC)
-23.16%
TTM Avg
-53.28%
3Y Avg
-63.06%
5Y Avg
-59.41%
Market Cap
$805.31M
Return on Invested Capital (ROIC)
9.20%
TTM Avg
13.08%
3Y Avg
19.17%
5Y Avg
23.78%
Market Cap
$807.61M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$780.99M
Return on Invested Capital (ROIC)
-42.83%
TTM Avg
-51.53%
3Y Avg
-51.53%
5Y Avg
-51.53%
Market Cap
$816.88M
Return on Invested Capital (ROIC)
-23.80%
TTM Avg
-58.06%
3Y Avg
-39.20%
5Y Avg
-32.57%
Market Cap
$817.67M
Return on Invested Capital (ROIC)
-7.99%
TTM Avg
-8.85%
3Y Avg
-21.37%
5Y Avg
-42.56%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AdaptHealth Corp. (AHCO) | $795.58M | -0.26% | 3.92% | -1.69% | 3.44% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $796.03M | -9.77% | 8.57% | -11.39% | -51.99% |
| Geron Corporation (GERN)vs › | $790.35M | -8.34% | -22.82% | -51.67% | -50.32% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $787.65M | -23.16% | -53.28% | -63.06% | -59.41% |
| InMode Ltd. (INMD)vs › | $805.31M | 9.20% | 13.08% | 19.17% | 23.78% |
| Apnimed, Inc. (APMD)vs › | $807.61M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $780.99M | -42.83% | -51.53% | -51.53% | -51.53% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $816.88M | -23.80% | -58.06% | -39.20% | -32.57% |
| Ardelyx, Inc. (ARDX)vs › | $817.67M | -7.99% | -8.85% | -21.37% | -42.56% |
| Mesa Laboratories, Inc. (MLAB)vs › | $772.37M | 3.29% | 2.60% | -15.46% | -9.88% |
ROIC
-0.3%
ROE
-16.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -0.26% |
| 2026-04-10 | 5.60% |
| 2025-12-31 | 6.18% |
| 2025-09-30 | 4.06% |
| 2025-06-30 | 4.01% |
| 2025-03-31 | 4.37% |
| 2024-12-31 | 4.67% |
| 2024-09-30 | -1.32% |
| 2024-06-30 | -14.57% |
| 2024-03-31 | -14.17% |
| 2023-12-31 | -14.87% |
| 2023-09-30 | -8.20% |
| 2023-06-30 | 2.58% |
| 2023-03-31 | 2.52% |
| 2022-12-31 | 2.96% |
| 2022-09-30 | 3.71% |
| 2022-06-30 | 4.22% |
| 2022-03-31 | 4.58% |
| 2021-12-31 | 3.92% |
| 2021-09-30 | 3.59% |
| 2021-06-30 | 3.02% |
| 2021-03-31 | 1.90% |
| 2020-12-31 | 4.96% |
| 2020-09-30 | 3.04% |
| 2020-06-30 | 4.80% |
| 2020-03-31 | 1.23% |
| 2019-12-31 | -0.69% |
| 2019-09-30 | -0.85% |
| 2019-06-30 | -0.68% |
| 2019-03-31 | -0.42% |
| 2018-12-31 | -0.35% |
